Mediterranean private equity firm, Mediterrania, makes its fourth investment from $686 million Fund IV
Mediterrania Capital Partners, a Malta-based private equity firm, has been actively investing and realizing returns in North and Sub-Saharan Africa, particularly in the medical devices and healthcare sectors.
Recent Investments: - The firm made its fourth investment from its recently closed mid-cap Fund IV, backing the medical devices arm of a recently exited portfolio company. The exact amount invested was not specified in the article.
The firm's focus on these sectors is evident in their recent activities. In July 2025, Mediterrania announced the final close of its fourth fund at €600 million, indicating ongoing fundraising momentum and capacity for further investments.
Recent Exits: - In April 2025, Mediterrania fully exited its investment in Akdital through its MC III fund, achieving strong financial returns and impact. The details about the identity of the portfolio company from which the medical devices arm was exited were not provided in the article. - Similarly, Mediterrania exited Dislog, a leading FMCG manufacturer and distributor in Morocco, in April 2025. The exact location of the medical devices company is also not specified in the article.
Mediterrania Capital Partners has a strong presence, with its headquarters in Ta' Xbiex, Malta, and offices in Abidjan and Barcelona. The firm's latest deployment for the medical devices arm of a recently exited portfolio company marks the third full exit for Mediterrania Capital from Fund III and the fourth deployment for the firm from its mid-cap Fund IV.
Additionally, another investor, CDG Invest Growth, has committed capital to a medical devices company, but the identity of the company was not disclosed in the article.
These strategic moves by Mediterrania Capital Partners underscore their commitment to investing in and supporting growth in the medical devices and healthcare sectors across their target regions.
- Mediterrania Capital Partners' investment in the medical devices arm of a recently exited portfolio company demonstrates their continued commitment to the finance of medical devices and healthcare sectors across North and Sub-Saharan Africa.
- The strong financial returns achieved through Mediterrania Capital Partners' full exit from Akdital and Dislog, along with their ongoing fundraising momentum, indicate their dedication to fostering growth within the medical devices and healthcare industries in their target regions.
